The Receding Specialty of Infectious Diseases and Implications for U.S. Healthcare

• by Gonzalo Bearman, Rebecca Mullin, Priya Nori

• December 10, 2025

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis

• by Mark Ebell, Peter Kurotschka

• May 12, 2026

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.

• by Andrea Surnit

• May 5, 2026

• 5 min

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection

• by Laura Marcos-Villar, Beatriz Perdiguero, Laura Sin, Enrique Álvarez, Sara Flores, José M. Casasnovas, Tirso Pons, Carlos Oscar S. Sorzano, Daniel del Hoyo, Philipp Lapuhs, María J. Alonso, Mariano Esteban, Carmen Elena Gómez

• May 5, 2026